Completed OBSERVATIONAL NCT03830255

Effect of Genetic Polymorphism on Calcineurin Inhibitors Levels in Egyptian Renal Transplant Patients

Calcineurin Inhibitors Among Egyptian Renal Transplant Patients: a Pharmacognetic Based Study.

Sponsor: Ain Shams University

Updated 7 times since 2019 Last updated: Mar 25, 2021 Started: Mar 1, 2017 Primary completion: Oct 1, 2019 Completion: Mar 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03830255, this observational or N/A phase trial focuses on Renal Transplantation and remains completed. Sponsored by Ain Shams University, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Apr 2021 — Dec 2021 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
Mar 2019 — Nov 2020 [monthly]

Recruiting

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University
Helwan University

Data source: Helwan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt